1. 1211PHyperprogression during immuno-checkpoint inhibitors (ICIs): A clinically significant problem?. (23rd October 2018) Authors: Farè, E; Sdao, S; Damian, S; Cresta, S; Del Vecchio, M; Di Bartolomeo, M; Di Guardo, L A; Duca, M; Indini, A; Necchi, A; Niger, M; Prisciandaro, M; Procopio, G; Raggi, D; Verzoni, E; Pruneri, G; Di Nicola, M; de Braud, F G M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1258PBaseline predictive factors for efficacy of anti-PD1 used in first line in melanoma patients: An Italian melanoma intergroup study. (23rd October 2018) Authors: Marconcini, R; Tanda, E; Di Guardo, L A; Nigro, O; Fava, P; Todisco, A; Morgese, F; Cortellini, A; Stroppa, E; Gallizzi, G; Festino, L; Grego, E; Quadrini, S; Orlandini, C; Nuzzo, A; Manacorda, S; Bloise, F; Indini, A; Astrua, C; Falcone, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗